Overall GLP-1 prescribing rates (GLP-1 RA prescriptions per total prescriptions) in September 2025 remained stable relative to June 2025 (+4.6%)
Nausea is the most common side-effect GLP-1 symptom, followed by vomiting, sour burps, heartburn and gastroparesis Side-Effect Profile of GLP-1s, from Worst to Best (% reflects estimated number of patients with GI side-effects) 50% Semaglutide (Ozempic, Rybelsus, Wegovy) 40% Tirzepatide (Saxenda, Mounjaro) 40% Liraglutide (Victoza, Saxenda) 30% Lixisenatide (Adlyxin USA, Lyxumia UK) 10% Dulaglutide (Trulicity) 10% Exenatide (Byetta, Bydureon) Wegovy, Mounjaro, and Saxenda FDA-approved for weight loss
It strengthens the immune system, enabling the body to fight infections more effectively
Retatrutide commercializzato da Peptidi Online Italia venduto esclusivamente per scopi di ricerca scientifica in vitro e su modelli animali, condotta da personale qualificato in laboratori autorizzati
This results from the metabolic shift occurring as your body adapts to reduced caloric intake and enhanced fat oxidation